Paper of the month
31.03.2022 March 2022: Long-term outcomes from the BrighTNess trial support inclusion of carboplatin in neoadjuvant chemotherapy for early-stage TNBC.
We are pleased to inform you that 4-year follow-up data from the BrighTNess trial has been published in Annals of Oncology.
28.02.2022 February 2022: Effects of capecitabine as part of neo-/adjuvant chemotherapy
We are pleased to inform you that a meta-analysis of capecitabine effect as part of neo-/adjuvant chemotherapy including 15,993 patients from 13 randomized trials has been published in European Journal of Cancer.
31.01.2022 January 2022: pCR in the breast and axillary lymph nodes correlates with iDFS – results from GeparOcto trial
We are pleased to inform you that an exploratory analysis of the randomized phase III GrparOcto trial has been published in Cancer
31.12.2021 December 2021: mdm2 gene amplification in luminal breast cancer
A biomarker analysis in luminal breast cancer using a humanized tumor mouse (HTM) model has been published in International Journal of Cancer.
31.12.2021 December 2021: CDK4/6 inhibitors in the treatment of patients with early breast cancer
We are delighted to inform you that an overview of data on CDK4/6 inhibitors in the treatment of breast cancer has been published in Breast.